Synergy Pharmaceuticals LLC
(Other OTC/NBB : SGYP)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Other
MYOKMyoKardia, Inc. 0.37%222.971.8%$514.75m
HZNPHorizon Therapeutics Plc 1.81%77.445.8%$157.77m
VRXValeant Pharmaceuticals International, Inc. 2.00%18.3614.1%$108.03m
JAZZJazz Pharmaceuticals Plc -0.61%150.262.4%$80.09m
CTLTCatalent, Inc. 0.69%94.042.1%$78.96m
BHCBausch Health Cos., Inc. 2.00%18.360.0%$69.59m
UTHRUnited Therapeutics Corp. 0.56%122.7814.1%$49.00m
ICLRICON plc -1.87%194.354.3%$47.08m
SAGESAGE Therapeutics, Inc. 0.97%71.518.6%$44.61m
ENDPEndo International Plc 0.00%5.798.7%$38.62m
ARGXargenx SE -0.72%250.420.0%$37.39m
ZGNXZogenix, Inc. 1.38%21.297.5%$35.17m
AMRNAmarin Corp. Plc -0.80%4.981.5%$33.35m
PRGOPerrigo Co. Plc 0.26%45.606.8%$32.08m
CTICCTI BioPharma Corp. 4.79%3.501.8%$31.00m

Company Profile

Synergy Pharmaceuticals LLC engages on the development and commercialization of novel gastrointestinal therapies. Its commercial product, plecanatide, is marketed under the trademark name TRULANCE, which seeks to treat adults with chronic idiopathic constipation and irritable bowel syndrome with constipation. The company was founded by Kunwar Shailubhai and is headquartered in New York, NY.